Evidence map›Paper›PMID 35755627›Full record

ArticleComprehensive psychoneuroendocrinology2020

Most oxytocin administration studies are statistically underpowered to reliably detect (or reject) a wide range of effect sizes.

Daniel S Quintana

Abstract read
In one paragraph

Article in Comprehensive psychoneuroendocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in behavioral neuroscience · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Daniel S QuintanaNORMENT, Division of Mental Health and Addiction, University of Oslo, And Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neuropeptide oxytocin has attracted substantial research interest for its role in behaviour and cognition; however, the evidence for its effects have been mixed. Meta-analysis is viewed as the gold-standard for synthesizing evidence, but the evidential value of a meta-analysis is dependent on the evidential value of the studies it synthesizes, and the analytical approaches used to derive conclusions. To assess the evidential value of oxytocin administration meta-analyses, this study calculated the statistical power of 107 studies from 35 meta-analyses and assessed the statistical equivalence of reported results. The mean statistical power across all studies was 12.2% and there has been no noticeable improvement in power over an eight-year period. None of the 26 non-significant meta-analyses were statistically equivalent, assuming a smallest effect size of interest of 0.1. Altogether, most oxytocin treatment study designs are statistically underpowered to either detect or reject a wide range of worthwhile effect sizes.

Indexed as

NeuroendocrinologyOxytocinSocial behaviourStatistics

Identifiers

PMID35755627
PMCPMC9216440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.